期刊文献+

新型糖基化生长抑素的合成及^(99)Tc^m标记 被引量:2

Synthesis of a Novel Glycosylated Somatostatin and Its ^(99)Tc^m Radiolabeling
下载PDF
导出
摘要 通过一系列氨羧缩合反应合成了双功能螯合剂硫代乙酰基-巯基乙酰-二甘氨酰-赖氨酸(S-Acetyl-MAG2Lys),并以生长抑素(somatostatin,SMS)、葡聚糖-10(Dextran10,Dx10)及S-Acetyl-MAG2Lys为原料,合成了糖基化生长抑素配体化合物(SMS-Dx10-MAG2Lys);利用酒石酸钠转换配合进行了SMS-Dx10-MAG2Lys的99Tcm标记,重点探讨了99Tcm标记条件及标记物的体外稳定性。结果表明,合成的双功能螯合剂S-Acetyl-MAG2Lys和配体化合物SMS-Dx10-MAG2Lys可成功用于99Tcm的放射标记,在最佳标记条件:0.3 g/L SnCl2,5 g/L SMS-Dx10-MAG2Lys,标记介质pH=9.5,室温下反应30 min,99Tcm-MAG2Lys-Dx10-SMS标记率约为50%,经分离纯化后,其放射化学纯度大于99%,标记物体外稳定,为进一步研究99Tcm-MAG2Lys-Dx10-SMS体内生物学特性提供了依据。 A new bifunctional chelator S-Acetyl-mercaptoacetyl-glycyl-glycyl-lysine (S-Acetyl- MAG2Lys) was synthesized. Natural somatostatin, dextran-10 and S-Acetyl-MAG2Lys were used to prepare somatostatin-dextran-MAG2Lys (SMS-Dx^10-MAG2Lys) conjugate. The SMS- Dx^10-MAG2Lys was radiolabeled with ^99Tc^m by using sodium tartrate as a transchelator. The ^99Tc^mMAG2 Lys-Dx^10- SMS radiolabeling conditions and its in vitro stability were studied in detail. The new chelator S-Acetyl-MAG2Lys and SMS-Dx^10-MAG2Lys conjugate were radiolabeled with ^99Tc^m successfully. The labeling efficiency of ^99Tc^m MAG2 Lys-Dx^10-SMS is approximately 50% under optimum conditions and its radiochemical purity is more than 99% after purification. The in vitro stability of the radiolabeled conjugate is satisfied. The results indicate that ^99Tc^m-MAG2Lys-Dx^100-SMS makes a base for its in vivo biological properties further investigation.
出处 《核化学与放射化学》 EI CAS CSCD 北大核心 2007年第3期178-183,共6页 Journal of Nuclear and Radiochemistry
基金 国家自然科学基金资助项目(30370421) 教育部留学回国人员科研启动基金资助项目(2004)
关键词 葡聚糖 生长抑素 ^99TC^M 标记 受体 dextran somatostatin ^99Tc^m radiolabeling receptor
  • 相关文献

参考文献17

  • 1Reichlin S.Somatostatin[J].N Engl J Med,1983,309:1 495-1 563.
  • 2Reubi J C,Hcki W H,Lamberts S W J.Hormone-Producing Gastrointestinal Tumors Contain a High Density of Somatostatin Receptors[J].J Clin Endocrinol Metab,1987,65:1 127-1 134.
  • 3Patel Y C.Somatostatin and Its Receptor Family[J].Frontiers in Nuroendocrinology,1999,20:157-198.
  • 4Behe M,Du J,Becker W,et al.Biodistribution,Blood Half-Life and Receptor Binding of a Somato-statin-Dextran Conjugate[J].Medical Oncology,2001,18:59-64.
  • 5Wulbrand U,Feldman M,Pfestroff A,et al.A Novel Somatostatin Conjugates With a High Affinity to All Five Somatostatin Receptor Subtypes[J].Cancer,2002,94(S4):1 293-1 297.
  • 6Holmberg A,Ljungstedt-Pahlman I,Marquez M,et al.In Vivo Properties of 125I-Somatostatin-Dextran Conjugates[J].Antibody Immunoconj Radio-pharmaceut,1995,8:171-177.
  • 7郭芳,何川,翟士桢,侯桂华,杜进.糖基化生长抑素的^(125)I标记及生物分布[J].同位素,2005,18(3):137-141. 被引量:6
  • 8Holmberg A,Marquez M,Westlin J E,et al.Labelling of Polypeptides With Technetium-99m by Using a Dextran Spacer[J].Cancer Res,1995,55:5 710-5 713.
  • 9崔海平,翟士桢,杜进.生长抑素-葡聚糖的^(99)Tc^m标记及体外结合分析[J].同位素,2006,19(2):83-86. 被引量:6
  • 10Du J,Hiltunen M,Marquez M,et al.Technetium-99m Labelling of Glycosylated Somatostatin-14[J].Appl Radiat Isot,2001,55:181-187.

二级参考文献30

  • 1郭芳,何川,翟士桢,侯桂华,杜进.糖基化生长抑素的^(125)I标记及生物分布[J].同位素,2005,18(3):137-141. 被引量:6
  • 2Reichlin S.Somatostatin [J].N Engl J Med,1983,309: 1 495-1 563.
  • 3Reubi JC,Hcki WH,Lamberts SWJ.Hormone-producing Gastrointestinal Tumors Contain a High Density of Somatostatin Receptors [J].J Clin Endocrinol Metab,1987,65: 1 127-1 134.
  • 4Patel YC.Somatostatin and Its Receptor Family [J].Frontiers in Nuroendocrinology,1999,20: 157-198.
  • 5Krenning EP,Kwekkeboom D,Bakker WH,et al.Somatostatin Receptor Scintigraphy With [111In-DTPA-D-phe1] and [123I-Tyr3]-Octreotide: the Rotterdam Experience With More Than 1 000 Patients [J].Eur J Nucl Med,1993,20: 716-731.
  • 6De Belder AN.Dextran [M].2nd Ed.Sweden: Pharmacia Print,Pharmacia,1990.35-45.
  • 7Bernstein A,Hurwitz E,Maron R,et al.Higher Antitumour Efficacy of Daunomycin When Linked to Dextran: in Vivo and in Vitro Studies [J].J Natl Cancer Inst,1978,60: 379-384.
  • 8Sherwood RF,Barid JK,Atkinson T,et al.Enhanced Plasma Persistence of Therapeutic Enzymes by Coupling to Soluble Dextran [J].Biochem J,1977,164: 461-464.
  • 9Holmberg A,Marquez M,Westlin JE,et al.Preparation,in Vitro Binding,and Technetium-99m Labelling of Somatostatin-dextran Conjugates[J].Antibody Immunoconj Radiopharmaceut,1994,7: 253-259.
  • 10Wulbrand U,Feldman M,Pfestroff A,et al.A Novel Somatostatin Conjugates With a High Affinity to All Five Somatostatin Receptor Subtypes[J].Cancer,2002,94(S4): 1 293-1 297.

共引文献7

同被引文献33

  • 1郭芳,何川,翟士桢,侯桂华,杜进.糖基化生长抑素的^(125)I标记及生物分布[J].同位素,2005,18(3):137-141. 被引量:6
  • 2崔海平,翟士桢,杜进.生长抑素-葡聚糖的^(99)Tc^m标记及体外结合分析[J].同位素,2006,19(2):83-86. 被引量:6
  • 3何川,翟士桢,杜进,戴皓洁,罗莎.^(99)Tc^m标记的新型糖基化生长抑素生物学评价[J].同位素,2007,20(1):11-15. 被引量:1
  • 4翟士桢,杜进,沈亦佳,胡春林,何川,赵磊.糖基化生长抑素^(90)Y标记及体内外生物学评价[J].核技术,2007,30(5):454-458. 被引量:1
  • 5Sharkey RM, Karacay H, Cardillo TM, et al. Imp roving the delivery of radionuelides for imaging and therapy of cancer using p retargeting methods[J]. Clin Cancer Res , 2005, 11(S): 7 109-7 121.
  • 6Mel Ton RG, Wibl In CN, Foster RL, et al. Covalent linkage of carboxypeptidase G2 to soluble dextrans: properties of conjugates and effect s on plasma persistence in mice[J]. Biochem Pharm, 1987, 36: 105-112.
  • 7Anthony LB, Woltering EA, Espanan GD, et al. Indium-111-pentetreotide prolongs survival in gastroenteropanereatic malignancies [J]. Seminars Nucl Med, 2002, 32: 123-132.
  • 8Manabe Y, Tsubota T, Haruta Y, et al. Production of a monoclonal antibody-methotrexate conjugate utilizing dextran T-40 and its biologic activity [J]. J Lab Clin Med, 1984, 104: 445-454.
  • 9Behe M, Du J, Becker W, et al. Biodist ribution, blood half-life and receptor binding of a somatostatin dextran conjugate [J]. Medical Oncology, 2001, 18: 59-64.
  • 10Wulbrand U, Feldman M, Pfestroffa, et al. A novel somatostatin conjugates with a high affinity to all five somatostatin receptor subtypes [J]. Cancer, 2002, 94 ($4): 1 293-1 297.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部